Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling

Platinum-based regimens have been routinely used in the clinical treatment of patients with esophageal squamous cell carcinoma (ESCC). However, administration of these drugs is frequently accompanied by drug resistance. Revealing the underlying mechanisms of the drug resistance and developing agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Wei, Fang, Tingting, Duan, Zhaoheng, Xiang, Dongfang, Wang, Yanxia, Zhang, Mengsi, Zhai, Fangzheng, Cui, Xiang, Yang, Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758349/
https://www.ncbi.nlm.nih.gov/pubmed/33363149
http://dx.doi.org/10.3389/fcell.2020.596788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758349/
https://www.ncbi.nlm.nih.gov/pubmed/33363149
http://dx.doi.org/10.3389/fcell.2020.596788

Ejemplares similares